Cargando…
Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice
Incorporating an emerging therapy as a new randomisation arm in a clinical trial that is open to recruitment would be desirable to researchers, regulators and patients to ensure that the trial remains current, new treatments are evaluated as quickly as possible, and the time and cost for determining...
Autores principales: | Cohen, Dena R, Todd, Susan, Gregory, Walter M, Brown, Julia M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457999/ https://www.ncbi.nlm.nih.gov/pubmed/25897686 http://dx.doi.org/10.1186/s13063-015-0697-y |
Ejemplares similares
-
A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia
por: Howard, Dena R., et al.
Publicado: (2021) -
Designs for adding a treatment arm to an ongoing clinical trial
por: Bennett, Maxine, et al.
Publicado: (2020) -
Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats
por: Lee, Kim May, et al.
Publicado: (2021) -
Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice
por: Emmerson, Jake, et al.
Publicado: (2021) -
Experiences in the design and implementation of phase II trials in CLL
por: Cohen, Dena R, et al.
Publicado: (2011)